Cargando…

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA(2) in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome

BACKGROUND: Apolipoprotein (Apo) B-48 is an intestinally derived lipoprotein that is expected to be a marker for cardiovascular disease (CVD). Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a vascular-specific inflammatory marker and important risk predictor of CVD. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyo-Sun, Jung, Chang Hee, Kim, Sung Rae, Jang, Hak Chul, Park, Cheol-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803547/ https://www.ncbi.nlm.nih.gov/pubmed/26754586 http://dx.doi.org/10.3803/EnM.2016.31.1.120

Ejemplares similares

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
por: Mita, Tomoya, et al.
Publicado: (2013)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
por: Vine, Donna F, et al.
Publicado: (2020)

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
por: Tsujita, Kenichi, et al.
Publicado: (2023)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin, Kevin W, et al.
Publicado: (2015)

Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
por: Tilija Pun, Nirmala, et al.
Publicado: (2022)

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020)

Chest pain as a possible side effect of pitavastatin (Livalo)
por: AlZahrani, Nada R., et al.
Publicado: (2019)

Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues
por: Makuc, Damjan, et al.
Publicado: (2013)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

ApoB48 as an Efficient Regulator of Intestinal Lipid Transport
por: Lo, Chunmin C., et al.
Publicado: (2020)

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
por: Meyers, Charles Daniel, et al.
Publicado: (2015)

Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes
por: Huang, Chung‐Huei, et al.
Publicado: (2016)

Effects of nanoparticle-mediated delivery of pitavastatin on atherosclerotic plaques in ApoE-knockout mice and THP-1-derived macrophages
por: Sun, Yujiao, et al.
Publicado: (2020)

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels
por: Liu, Huanyun, et al.
Publicado: (2017)

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Anticonvulsant and Antioxidant Effects of Pitavastatin Against Pentylenetetrazol-Induced Kindling in Mice
por: Faghihi, Nastaran, et al.
Publicado: (2017)

Ivermectin Augments the Anti-Cancer Activity of Pitavastatin in Ovarian Cancer Cells
por: Jawad, Mohammed Jasim, et al.
Publicado: (2023)

Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe (−/−) Mice
por: Katsuki, Shunsuke, et al.
Publicado: (2022)

Hypertensive Disorders of Pregnancy: Assessing the Significance of Lp(a) and ApoB Concentrations in a Romanian Cohort
por: Abu-Awwad, Simona-Alina, et al.
Publicado: (2023)

Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a
por: Lee, Naeun, et al.
Publicado: (2020)

Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats
por: Koladiya, Rajeshkumar U, et al.
Publicado: (2008)

Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
por: Kawai, Yasuyuki, et al.
Publicado: (2011)

Spectrophotometric Determination of Cefetamet Pivoxil Hydrochloride and Pitavastatin Calcium in Tablet Dosage form
por: Vadia, N. H., et al.
Publicado: (2008)

Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages
por: Zhang, Haijun, et al.
Publicado: (2016)

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2peoqrnudl20m5suvg0b9equuh